Wanbang Pharmaceutical Holding Group (002082.SZ): Approved Supplemental Drug Application for Chlorpromazine Hydrochloride Tablets

Wanbangde Pharmaceutical Holding Group (002082.SZ) announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Holding Group Pharmaceutical Group Co., Ltd., recently received the "Drug Supplement Application Approval Notification" issued by the National Medical Products Administration for Chlorpromazine Hydrochloride Tablets. Chlorpromazine Hydrochloride Tablets are a phenothiazine antipsychotic drug that can be used to treat schizophrenia, mania, nausea, vomiting due to various reasons, and intractable hiccups.